产品详情
靶点信息
EGFR | ||||
2 nM |
In vitro | DMSO | Warmed: 75 mg/mL (180.34 mM) | |
Water | Insoluble | ||
Ethanol | Insoluble | ||
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 24.04 mL | 120.22 mL | 240.44 mL |
0.5 mM | 4.81 mL | 24.04 mL | 48.09 mL |
1 mM | 2.4 mL | 12.02 mL | 24.04 mL |
5 mM | 0.48 mL | 2.4 mL | 4.81 mL |
*The above data is based on the productmolecular weight 415.9 . Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
目录号 | A10678 |
---|---|
作用机制 | Inhibitor (抑制剂) |
M. Wt | 415.9 |
Formula | C21H21N3O4.HCl |
Purity | >99% |
Storage | Store lyophilized at -20ºC, keep desiccated. |
CAS No. | 183320-51-6 |
Synonyms | Desmethyl Erlotinib,CP-473420, OSI420 |
SMILES | COCCOC1=C(C=C2C(=C1)N=CN=C2NC3=CC=CC(=C3)C#C)OCCO.Cl |
产品标签
Product Questions
Product Questions
CO-1686 (Rociletinib, AVL-301)
CO-1686是一种新型的口服靶向共价(不可逆)抑制剂,可抑制表皮生长因子受体(EGFR)的致癌突变形式,目…
PD153035 (HCl salt)
PD153035 (HCl salt)是EGFR酪氨酸激酶活性的极其有效和特异的抑制剂。
CL-387785 (EKI-785)
CL-387785是EGFR的不可逆抑制剂,IC50为370+/-120 pM;能够在功能水平上克服由T790M突变引起的抗药性。
Neratinib (HKI-272)
Neratinib (HKI-272)是一种酪氨酸激酶抑制剂。
Mubritinib (TAK 165)
Mubritinib (TAK 165)是一种有效的EGFR和p34cdc2抑制剂,IC50分别为6 nM和0.2 ?M。Mubritinib(TAK 165)也抑制p33cdk2和p33cd…
PKC 412 (Midostaurin)
PKC 412 (Midostaurin)是一种广谱蛋白激酶抑制剂。抑制常规PKC亚型α/β/γ,PDFRβ,VEGFR2,Syk,Flk-1,Flt3,Cdk1/B,…